We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

73 hedge funds and large institutions have $2.33B invested in PMV Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 14

114% more capital invested

Capital invested by funds: $1.09B → $2.33B (+$1.25B)

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

43% more funds holding

Funds holding: 51 → 73 (+22)

12.77% more ownership

Funds ownership: 72.59% → 85.36% (+13%)

Holders
73
Holders Change
+22
Holders Change %
+43.14%
% of All Funds
1.29%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
36
Increased
19
Reduced
11
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$44.7M
2
BlackRock
BlackRock
New York
+$31.5M
3
Alkeon Capital Management
Alkeon Capital Management
New York
+$25.6M
4
ACA
Avoro Capital Advisors
New York
+$19.6M
5
PA
Perceptive Advisors
New York
+$11M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$13.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$12.8M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$10.9M
4
AG
Artal Group
Luxembourg
-$7.1M
5
UBS AM
UBS AM
Illinois
-$6.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
26
UBS AM
Illinois
$12M -$6.09M -155,175 -44%
DM
27
Deerfield Management
New York
$11.5M +$5.38M +137,192 +274%
Northern Trust
28
Northern Trust
Illinois
$9.61M +$5.5M +140,300 +878%
Jennison Associates
29
Jennison Associates
New York
$9.14M -$55.2K -1,406 -0.9%
CC
30
Commodore Capital
New York
$7.69M +$4.9M +125,000 New
LGM
31
Logos Global Management
California
$6.15M -$1.96M -50,000 -33%
ACM
32
Asymmetry Capital Management
California
$5.94M +$2.81M +71,703 +288%
Charles Schwab
33
Charles Schwab
California
$5.12M +$3.26M +83,164 New
N
34
Nuveen
North Carolina
$3.08M +$1.96M +50,017 New
EC
35
EcoR1 Capital
California
$3.08M – – –
Bank of New York Mellon
36
Bank of New York Mellon
New York
$2.54M +$1.62M +41,294 New
Deutsche Bank
37
Deutsche Bank
Germany
$2.48M +$1.58M +40,296 New
JP Morgan Chase
38
JP Morgan Chase
New York
$2.28M +$1.06M +27,099 +271%
Morgan Stanley
39
Morgan Stanley
New York
$1.96M +$977K +24,896 +361%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$1.77M +$1.13M +28,736 New
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.6M +$1.02M +26,094 New
HS
42
HighVista Strategies
Massachusetts
$1.39M +$889K +22,654 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.27M +$811K +20,662 New
PPA
44
Parametric Portfolio Associates
Washington
$1.11M +$288K +7,351 +68%
Marshall Wace
45
Marshall Wace
United Kingdom
$996K +$635K +16,193 New
ACP
46
Acuta Capital Partners
California
$923K +$588K +15,000 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$857K +$546K +13,928 New
AC
48
Athanor Capital
New York
$710K +$453K +11,547 New
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$652K +$416K +10,600 New
JG
50
Jefferies Group
New York
$615K +$392K +10,000 New
1
2
3 4

PMVP Hedge Fund Activity: Q4 2020 in Review

73 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q4 2020, worth a combined $2.33B — up 114% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new PMVP positions and 14 closed out — a net gain of 22 holders — while 19 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $44.7M. The largest seller was Wellington Management Group, cutting an estimated $13.4M.

  • 73 institutional investors held PMV Pharmaceuticals (PMVP) as of Q4 2020, up from 51 in Q3 2020.
  • Funds reported $2.33B of PMV Pharmaceuticals stock for Q4 2020, up 114% quarter-over-quarter.
  • 36 funds opened new PMV Pharmaceuticals positions in Q4 2020 and 14 closed out, a net change of +22 holders.
  • The largest PMV Pharmaceuticals buyer in Q4 2020 was Vanguard Group, an estimated $44.7M added.
  • The largest PMV Pharmaceuticals seller in Q4 2020 was Wellington Management Group, an estimated $13.4M sold.

Based on aggregated 13F filings for Q4 2020.